ARTICLE | Company News
Abgenix, MDS Proteomics in antibody deal
June 29, 2001 7:00 AM UTC
The companies will develop and market antibody therapeutics using ABGX's human antibody technology and MDS Proteomics' proteomics systems to identify targets. They will identify up to 150 targets for ...